Immunohistochemical evaluation of 95 bone marrow reactive plasmacytoses

Pathology and Oncology Research

Volumn 15, Issue 1, 2009, Pages 25-29

  Ioannou, Maria G ^a   Stathakis, Efstathios ^a   Lazaris, Andreas C ^a   Papathomas, Thomas ^a,b   Tsiambas, Evangelos ^a   Koukoulis, George K ^a  

^a UNIVERSITY OF THESSALY   (Greece)

^b NONE   (Greece)

Author keywords

Bone marrow biopsies; CD56; Cyclin D1; Immunohistology; Plasma cell myeloma; Reactive plasmacytosis

Indexed keywords

CD56 ANTIGEN; CYCLIN D1; NERVE CELL ADHESION MOLECULE; SYNDECAN 1;

ANTIGEN EXPRESSION; ARTICLE; BONE MARROW; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LIGHT CHAIN; MAJOR CLINICAL STUDY; MONOCLONAL IMMUNOGLOBULINEMIA; MULTIPLE MYELOMA; OSTEOBLAST; PHENOTYPE; PLASMA CELL; PLASMACYTOSIS;

ANTIGENS, CD56; BONE MARROW; CYCLIN D1; HUMANS; IMMUNOENZYME TECHNIQUES; IMMUNOGLOBULIN LAMBDA-CHAINS; MULTIPLE MYELOMA; NEURAL CELL ADHESION MOLECULES; PLASMA CELLS; RETROSPECTIVE STUDIES;

EID: 67749102335     PISSN: 12194956     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12253-008-9069-1     Document Type: Article

References (25)

1. Bain BJ, Clark DM, Lampert IA, Wilkins BS (2001) Bone marrow pathology. Blackwell Science, Oxford
2. BK Hyun D Kwa H Gabaldon JK Ashton 1976 Reactive plasmacytic lesions of the bone marrow Am J Clin Pathol 65 921 928
3. A Wei S Juneja 2003 Bone marrow immunohistology of plasma cell neoplasms J Clin Pathol 56 406 411 (Pubitemid 36724205)
4. Grogan TM, Van Camp B, Kyle RA, Muller-Hermelink HK, Harris NL (2001) Plasma cell neoplasms. In: Jaffe ES, Harris NL, Stein H, Vardiman JW (eds) World Health Organization classification of tumours. Pathology and genetics of tumours of haematopoietic and lymphoid tissues. IARC Press, Lyon, pp 142-156
5. Dick FR (2002) Chronic lymphoproliferative disorders, immunoproliferative disorders, and malignant lymphoma. In: McClatchey KD, Weinberg RW, Reter RE, Foley T (eds) Clinical laboratory medicine. Lippincott Williams & Wilkins, Philadelphia, pp 923-963
6. SA Ely DM Knowles 2002 Expression of CD56/neural cell adhesion molecule correlates with the presence of lytic bone lesions in multiple myeloma and distinguishes myeloma from monoclonal gammopathy of undetermined significance and lymphomas with plasmacytoid differentiation Am J Pathol 160 1293 1299
7. C Pellat-Deceunynck S Barille G Jego 1998 The absence of CD56 (NCAM) on malignant plasma cells is a hallmark of plasma cell leukemia and of a special subset of multiple myeloma Leukemia 12 1977 1982
8. A Rawstron S Barrans D Blythe 1999 Distribution of myeloma plasma cells in peripheral blood and bone marrow correlates with CD56 expression Br J Haematol 104 138 143
9. C Pellat-Deceunynck S Barille D Puthier 1995 Adhesion molecules on human myeloma cells: significant changes in expression related to malignancy, tumor spreading, and immortalization Cancer Res 55 3647 3653
10. IM Dahl T Rasmussen G Kauric A Husebekk 2002 Differential expression of CD56 and CD44 in the evolution of the extramedullary myeloma Br J Haematol 116 273 277
11. N Sahara A Takeshita K Shigeno 2002 Clinicopathological and prognostic characteristics of CD56-negative multiple myeloma Br J Haematol 117 882 885
12. CV Hedvat RL Comenzo J Teruya-Feldstein 2003 Insights into extramedullary tumour cell growth revealed by expression profiling of human plasmacytomas and multiple myeloma Br J Haematol 122 728 744
13. M Kremer G Ott M Nathrath 2005 Primary extramedullary plasmacytoma and multiple myeloma: phenotypic differences revealed by immunohistochemical analysis J Pathol 205 92 101
14. N Sahara A Takeshita 2004 Prognostic significance of surface markers expressed in multiple myeloma: CD56 and other antigens Leuk Lymphoma 45 61 65
15. B Van Camp BG Durie C Spier 1990 Plasma cells in multiple myeloma express a natural killer cell-associated antigen: CD56 (NKH-1; Leu-19) Blood 76 377 382
16. P Martin A Santon C Bellas 2004 Neural cell adhesion molecule expression in plasma cells in bone marrow biopsies and aspirates allows discrimination between multiple myeloma, monoclonal gammopathy of uncertain significance and polyclonal plasmacytosis Histopathology 44 375 380
17. CH Dunphy MK Nies DA Gabriel 2007 Correlation of plasma cell percentages by CD138 immunohistochemistry, cyclin D1 status, and CD56 expression with clinical parameters and overall survival in plasma cell myeloma Appl Immunohistochem Mol Morphol 15 248 254
18. F Fend M Kremer 2007 Diagnosis and classification of malignant lymphoma and related entities in the bone marrow trephine biopsy Pathobiology 74 133 143
19. M Kremer L Quintanilla-Martínez J Nährig C Von Schilling F Fend 2005 Immunohistochemistry in bone marrow pathology: a useful adjunct for morphologic diagnosis Virchows Arch 447 920 937
20. S Sukpanichnant JB Cousar A Leelasiri SE Graber JP Greer RD Collins 1994 Diagnostic criteria and histologic grading in multiple myeloma: histologic and immunohistologic analysis of 176 cases with clinical correlation Hum Pathol 25 308 318
21. JD Cotelingam 2003 Bone marrow biopsy: interpretive guidelines for the surgical pathologist Adv Anat Pathol 10 8 26
22. Brunning RD (2004) Bone Marrow. In: Rosai J, Houston M (eds) Rosai and Ackerman's surgical pathology. Mosby, St. Louis, pp 2099-2108
23. R Bataille G Jégo N Robillard 2006 The phenotype of normal, reactive and malignant plasma cells. Identification of "many and multiple myelomas" and of new targets for myeloma therapy Haematologica 91 1234 1240
24. O Sezer U Heider I Zavrski K Possinger 2001 Differentiation of monoclonal gammopathy of undetermined significance and multiple myeloma using flow cytometric characteristics of plasma cells Haematologica 86 837 843
25. KN Naresh I Lampert R Hasserjian 2006 Optimal processing of bone marrow trephine biopsy: the Hammersmith Protocol J Clin Pathol 59 903 911